List of Loxo Oncology patents

List of Loxo Oncology patents

List of Visiongate, Inc. patents

List of Kheiron Medical Technologies patents

List of Precision BioSciences patents

List of ion trap patents

List of awards received by Sylvester Stallone

Patents where

Current Assignee

Name

is

Loxo Oncology

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10137127 Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-A]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide	Patent 10137127 was granted and assigned to Loxo Oncology on November, 2018 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10137127	November 27, 2018
	‌ US Patent 11484535 Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a] pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide	Patent 11484535 was granted and assigned to Loxo Oncology on November, 2022 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	11484535	November 1, 2022
	‌ US Patent 10045991 Methods of treating pediatric cancers	Patent 10045991 was granted and assigned to Loxo Oncology on August, 2018 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10045991	August 14, 2018
	‌ US Patent 10588908 Methods of treating pediatric cancers	Patent 10588908 was granted and assigned to Loxo Oncology on March, 2020 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10588908	March 17, 2020
	‌ US Patent 10786489 Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrile	Patent 10786489 was granted and assigned to Loxo Oncology on September, 2020 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10786489	September 29, 2020
	‌ US Patent 10668072 Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide		Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10668072	June 2, 2020
	‌ US Patent 11191766 Methods of treating pediatric cancers	Patent 11191766 was granted and assigned to Loxo Oncology on December, 2021 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	11191766	December 7, 2021
	‌ US Patent 9975897 Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase	Patent 9975897 was granted and assigned to Loxo Oncology on May, 2018 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	9975897	May 22, 2018
	‌ US Patent 10342780 Compounds useful as kinase inhibitors	Patent 10342780 was granted and assigned to Loxo Oncology on July, 2019 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10342780	July 9, 2019
	‌ US Patent 10399990 Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer	Patent 10399990 was granted and assigned to Loxo Oncology on September, 2019 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10399990	September 3, 2019
	‌ US Patent 10399989 Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer	Patent 10399989 was granted and assigned to Loxo Oncology on September, 2019 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10399989	September 3, 2019
	‌ US Patent 10538524 Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase	Patent 10538524 was granted and assigned to Loxo Oncology on January, 2020 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10538524	January 21, 2020
	‌ US Patent 10695323 Compounds useful as kinase inhibitors		Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10695323	June 30, 2020
	‌ US Patent 10464905 Compounds useful as kinase inhibitors	Patent 10464905 was granted and assigned to Loxo Oncology on November, 2019 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	10464905	November 5, 2019
	‌ US Patent 12109193 Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide	Patent 12109193 was granted and assigned to Loxo Oncology on October, 2024 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	12109193	October 8, 2024
	‌ US Patent 12102621 Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile	Patent 12102621 was granted and assigned to Loxo Oncology on October, 2024 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	12102621	October 1, 2024
	‌ US Patent 10611766 Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer	Patent 10611766 was granted and assigned to Loxo Oncology on April, 2020 by the United States Patent and Trademark Office.		Loxo Oncology		United States Patent and Trademark Office	10611766	April 7, 2020
	‌ US Patent 11963950 Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile	Patent 11963950 was granted and assigned to Loxo Oncology on April, 2024 by the United States Patent and Trademark Office.	Loxo Oncology	Loxo Oncology		United States Patent and Trademark Office	11963950	April 23, 2024

18 results

0 selected

18 results

0 selected